CD4 and neoplasm: AN3025 significantly increased tumor infiltrating CD8+ T cells (Figures 4C, D) and CD4+ T cells (Figures 4E, F), while anti-mouse PD-1 antibody showed less effects on tumor infiltrating CD8+ and CD4+ T cell in the same study (Figures 4C–F).